Baxter International Inc.

Robert L. Parkinson, Jr., age 58, is Chairman and Chief Executive Officer of Baxter, having served in that capacity since April 2004. Prior to joining Baxter, Mr. Parkinson was Dean of Loyola University Chicago's School of Business Administration and Graduate School of Business from 2002 to 2004. He retired from Abbott Laboratories in 2001 following a 25-year career, having served in a variety of domestic and international management and leadership positions, including as President and Chief Operating Officer. Mr. Parkinson also serves on the boards of directors of Chicago-based Northwestern Memorial Hospital and the Northwestern Memorial Foundation as well as Loyola University Chicago's Board of Trustees.

Karenann Terrell is corporate vice president and chief information officer at Baxter and has responsibility for the company's global information technology function supporting Baxter's businesses worldwide, including its sales, manufacturing, science and technology, and supply chain operations. Terrell joined Baxter in April 2006 from DaimlerChrysler Corporation where she most recently served as vice president and chief information officer, Chrysler Group and Mercedes Benz North America. Prior to this, Terrell spent 16 years at General Motors where she had responsibility for brand development and e-business management. Terrell serves on the Mayor's Council of Technology Advisors for the City of Chicago and is a member of the Board of Directors for Women in Technology International. Terrell earned her master's degree in electrical engineering from Purdue University, and her Bachelor of Science in the same field from General Motors Institute.

Dr. Riedel is a corporate vice president and the chief scientific officer of Baxter International Inc., having served in that capacity since March 2001. He joined Baxter in 1998 as president of the recombinant unit within Baxter's BioScience business. Prior to joining Baxter, he was head of worldwide biotechnology and head of worldwide core research functions at Hoechst Marion Roussel. Dr. Riedel received his Ph.D. in biochemistry from the University of Frankfurt in 1983 and was a postdoctoral fellow at Harvard University from 1984 until 1987. Currently, Dr. Riedel is an adjunct professor at Boston University.

Robert M. Davis is corporate vice president and chief financial officer, overseeing Baxter's global financial operations. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served as director of corporate financial planning. He held numerous positions, including assistant treasurer, director of planning and tax counsel. As assistant treasurer, he had responsibility for overseeing global treasury operations, including cash flow planning, capital markets, working capital management and affiliate funding worldwide. Davis currently serves on the Board of Trustees for Rush University Medical Center and is a member of its Finance Committee. Davis earned his juris doctorate from Northwestern University School of Law and his master's degree from Northwestern University's Kellogg Graduate School of Management, after graduating from Miami University with a bachelor's degree in finance.

Bruce McGillivray is corporate vice president and president of Baxter's Renal business. In this position, he is responsible for the development and worldwide marketing of Baxter's peritoneal and hemodialysis products and services. McGillivray has been with Baxter since 1980, joining the company as a territory manager for the Hospital Division in Canada. Throughout the years, he has held a succession of senior positions. He was named president of Baxter Canada in 1997 and in 2002, was named president of Renal Europe. McGillivray serves on the board of the Lake Forest School of Management. McGillivray has a degree in economics from York University and a master's degree in business administration from the University of Toronto.

Cheryl L. White is corporate vice president, quality at Baxter. Prior to assuming this position, White served as vice president, quality management for Baxter's BioScience business in Westlake, California. She has held senior positions within the BioScience business with direct supervision over global manufacturing facilities and product development for biopharmaceutical products, biosurgery and vaccines. She played a vital leadership position in the successful validation, staffing and licensure of the ADVATE manufacturing facility in Neuchatel, Switzerland. Before joining the company in 1998, she managed quality control and quality assurance activities for Hybritech, at the time a division of Eli Lilly and Beckman Instruments. In addition, she spent nine years in academic research in the University of California system. White is the executive sponsor of Baxter's Global Inclusion Council and serves on the board of directors of The Baxter International Foundation. She is a member of the Regulatory Affairs Professional Society (RAPS) and the Parenteral Drug Association (PDA). White earned her master's degree in business administration from the University of California, Irvine, and a Bachelor of Arts in biology from the University of California, San Diego.

David P. Scharf is corporate vice president, deputy counsel, and corporate secretary for Baxter and is responsible for the Transactions and Governance Law Team. Prior to joining Baxter in 2005, Scharf served as associate general counsel for Guidant Corporation, where his responsibilities included corporate governance, complex transactions, and capital market matters. Prior to Guidant, Scharf handled similar matters as assistant general counsel with Sears, Roebuck and Co. and was an associate with Baker & Daniels. Scharf received his law degree from the University of Chicago, where he was a member of the law review, and his bachelor's degree in finance from Indiana University. Prior to law school, Scharf worked in foreign exchange derivatives for a predecessor of UBS.

Gerald Lema is corporate vice president and president of Baxter's Asia Pacific region. He has responsibility for the company's operations in Japan, Australia and New Zealand, China/Hong Kong, India, North Asia and South East Asia. Lema has more than 20 years of pharmaceutical, diagnostics and healthcare experience in Asia, Japan, Europe, North/South America and the Middle East/Africa. Prior to joining Baxter in 2005, Lema held several positions in sales, marketing and business development at Abbott Laboratories. His most recent position with Abbott was corporate vice president, Asia Pacific, and chairman and representative director, Abbott Japan, in Tokyo. Lema earned a Bachelor of Science in engineering from Universidad del Valle, Colombia and a master's degree in business administration from the Freeman School of Business, Tulane University, New Orleans.

James Michael Gatling is corporate vice president, global manufacturing at Baxter. He is responsible for the global manufacturing operations for Baxter's Medication Delivery and Renal businesses, and for Environment, Health & Safety. Gatling leads Baxter's Manufacturing Council, which is responsible for identifying and addressing critical worldwide manufacturing issues. Gatling joined Baxter in 1975 as an industrial engineer and progressed through a variety of positions in manufacturing. His previous positions include plant manager for Baxter facilities in Cleveland, Mississippi, and Marion, North Carolina. Gatling assumed responsibility for I.V. Systems manufacturing operations in 1994, and in May 1996 was promoted to vice president of global manufacturing operations, I.V. Systems/Medical Products. In December 1996, Gatling was named corporate vice president, I.V. Systems/Medical Products. He also assumed responsibility for Renal manufacturing in 1997. Prior to joining Baxter, Gatling worked at Anderson Clayton and Northern Electric. Gatling received a bachelor's degree in industrial management from Mississippi State University.

Michael J. Baughman is corporate vice president and controller at Baxter. Baughman joined Baxter in 2003 as the vice president of corporate audit. He was appointed to the role of corporate controller in March 2005. Before joining Baxter, Baughman had a 16-year career at PricewaterhouseCoopers LLP, during which he held a number of senior roles, including audit partner and partner in the firm's mergers and acquisitions practice. Baughman is a board member of the Baxter Credit Union, as well as a member of the American Institute of Certified Public Accountants and The Corporate Executive Board, Controllers' Leadership Roundtable. Baughman received a bachelor's degree in business administration from the University of Michigan and is a Certified Public Accountant

Susan R. Lichtenstein is corporate vice president and general counsel. In this role, she serves as the chief legal officer and is responsible for global communications, government affairs and public policy. Lichtenstein's career has spanned corporate, government, and private law practice. Prior to joining Baxter in March 2005, Lichtenstein served as general counsel to the governor of Illinois. Previously, Lichtenstein worked in the telecommunications industry where she served as general counsel and corporate secretary for both Ameritech Corporation and Tellabs, Inc. She also served as deputy corporation counsel for the City of Chicago after spending a decade with Schiff Hardin & Waite, where she was a partner working on complex litigation, corporate counseling and internal investigations, with particular emphasis on regulated industries. Lichtenstein serves on the boards of numerous civic and philanthropic organizations, including the Lyric Opera of Chicago, the Ravinia Festival, and Olin-Sang-Ruby Union Institute. She is a member of The Economic Club of Chicago, The Executives' Club of Chicago, The Chicago Network and is a steering committee member of the Senior Businesswomen's Forum. Additionally, Lichtenstein was co-founder and co-chair of the Women in Business, Politics and Powers symposium series. Lichtenstein received a Bachelor of Arts from the University of Minnesota and a law degree from Northwestern University Law School.

Chairman and Chief Executive Officer since December 2006. Previously Chief Executive Officer of HB Fuller Company, a manufacturer of adhesives, sealants, coatings, paints and other specialty chemical products 1998-2006, and Chairman of HB Fuller Company from 1999-2006.

Blake E. Devitt, age 62, has served as a Director of Baxter since 2005. Mr. Devitt retired in 2004 from the public accounting firm of Ernst & Young LLP. During his 33-year career at Ernst & Young, Mr. Devitt held several positions, including Senior Audit Partner and Director, Pharmaceutical and Medical Device Industry Practice, from 1994 to 2004.

Carole J. Shapazian, age 65, has served as a Director of Baxter since 2003. Ms. Shapazian served as Executive Vice President of Maytag Corporation, a producer of home and commercial appliances, and as President of Maytag's Home Solutions Group, from January 2000 to December 2000. Prior to that, she was Executive Vice President and Assistant Chief Operating Officer of Polaroid Corporation, a photographic equipment and supplies corporation, from 1998 to 1999. From 1997 to 1998, she served as Executive Vice President and President of Commercial Imaging for Polaroid.

Joseph B. Martin, M.D., Ph.D., age 70, has served as a Director of Baxter since 2002. Dr. Martin serves as Professor of Neurobiology at Harvard Medical School. From July 1997 to July 2007, Dr. Martin served as Dean of the Harvard Faculty of Medicine. He was Chancellor of the University of California, San Francisco from 1993 to 1997 and Dean of the UCSF School of Medicine from 1989 to 1993. From 1978 to 1989, he was chief of the neurology department of Massachusetts General Hospital and Professor of Neurology at Harvard Medical School.

Peter S. Hellman, age 59, has served as a Director of Baxter since 2005. From 2000 until his retirement in 2008, Mr. Hellman held various positions at Nordson Corporation, a manufacturer of systems that apply adhesives, sealants and coatings during manufacturing operations, the most recent of which was President and Chief Financial and Administrative Officer. From 1989 to 1999, Mr. Hellman held various positions with TRW Inc., the most recent of which was President and Chief Operating Officer. Mr. Hellman also serves as a director of Qwest Communications International Inc. and Owens-Illinois, Inc.

Thomas T. Stallkamp, age 62, has served as a Director of Baxter since 2000. Mr. Stallkamp has been an Industrial Partner in Ripplewood Holdings L.L.C., a New York private equity group, since 2004. From 2003 to 2004, he served as Chairman of MSX International, Inc., a global provider of technology-driven engineering, business and specialized staffing services, and from 2000 to 2003, he served as Vice-Chairman and Chief Executive Officer of MSX. From 1980 to 1999, Mr. Stallkamp held various positions with DaimlerChrysler Corporation and its predecessor Chrysler Corporation, the most recent of which was Vice Chairman and President. Mr. Stallkamp also serves as a director of BorgWarner Inc. and Honsel International Technologies S.A and a director and non-executive co-chairman of Asahi Tec Corporation.